TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985
TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups. January 12, 2007
TCL Archive Key Cancer Legislation Remains Unfinished as Congress Departs for Election. October 6, 2006
